Back to RHUMBLINE ADVISERS RHUMBLINE ADVISERS

SNPHYSNPHY
Showing 8 of 13 quarters

Position history for RHUMBLINE ADVISERSRHUMBLINE ADVISERS's holdings in SANTEN PHARMACEUTICAL UN ADR

RHUMBLINE ADVISERS holds 30 shares of SNPHY (SANTEN PHARMACEUTICAL UN ADR), worth $403 as of 2026-Q2.

Current Value

$403

Current Shares

30

Total Value Change

+$40

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
30
0.0%
$4030.0%$13.45
0
2026-Q1
Decreased
30
-97.5%
$3330.0%$10.36
0
2025-Q4
Unchanged
1,197
0.0%
$12,3290.0%$10.50
0
2025-Q3
Increased
1,197
+3890.0%
$13,4900.0%$10.95
20
2025-Q2
Unchanged
30
0.0%
$3480.0%$11.00
0
2025-Q1
Unchanged
30
0.0%
$2840.0%$9.52
0
2024-Q4
Unchanged
30
0.0%
$3030.0%$9.13
0
2024-Q3
Unchanged
30
0.0%
$3630.0%$12.38
0

Other major holders of SNPHY: GLENMEDE TRUST CO NA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used